Brief: Scandinavian ChemoTech Board Resolves On Rights Issue

Scandinavian ChemoTech AB

21/09/2022 08:26

Sept 21 (Reuters) - Scandinavian ChemoTech AB  CMOTECb.ST :
    * THE BOARD OF DIRECTORS RESOLVES ON A RIGHTS ISSUE OF UNITS OF APPROXIMATELY SEK 20.1
MILLION
    * DECIDED TO CARRY OUT A RIGHTS ISSUE OF UNITS CONSISTING OF SHARES AND WARRANTS OF SERIES
TO3 OF
APPROXIMATELY SEK 20.1 MILLION
    * RIGHTS ISSUE IS COVERED TO APPROXIMATELY 40 PERCENT THROUGH SUBSCRIPTION COMMITMENTS AND
UNDERWRITING COMMITMENTS
    * IF ALL WARRANTS OF SERIES TO3 IS EXERCISED, COMPANY CAN RECEIVE AN ADDITIONAL MAXIMUM OF
APPROXIMATELY SEK 40.1 MILLION
    * IN ADDITION, BOARD OF DIRECTORS HAS RESOLVED ON AN OVER-ALLOTMENT OPTION UP TO SEK 3.0
MILLION,
CONDITIONAL UPON RIGHTS ISSUE BEING OVERSUBSCRIBED

Source text for Eikon:  ID:nWkr8sKstl 
Further company coverage:  CMOTECb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))